|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 31/4439 | (2006.01) |
| (11) | Number of the document | 3226843 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15820351.3 |
| Date of filing the European patent application | 2015-12-03 | |
| (97) | Date of publication of the European application | 2017-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation | 2021-08-10 |
| (86) | Number | PCT/US2015/063671 |
| Date | 2015-12-03 |
| (87) | Number | WO 2016/090105 |
| Date | 2016-06-09 |
| (30) | Number | Date | Country code |
| 14196605 | 2014-12-05 | EP |
| (72) |
VERRECK, Geert, BE
|
| (73) |
Aragon Pharmaceuticals, Inc. ,
10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Priešvėžinės kompozicijos |
| ANTICANCER COMPOSITIONS |
| Payment date | Validity (years) | Amount | |
| 2022-11-24 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-12-03 |